Clinical Characteristics of the study cohort
| Variables | Pre-HAC-X n=391 | Post-HAC-X n=311 | p Value |
|---|---|---|---|
| Age (years) | 65.2±12.6 | 57.0±13.9 | <0.001 |
| Gender | 0.884 | ||
| Male (%) | 70.8 | 70.0 | |
| Female (%) | 29.2 | 30.0 | |
| Smoking status: | 0.009 | ||
| Current (%) | 18.2 | 29.6 | |
| Ex-smoker (%) | 30.4 | 31.9 | |
| Never (%) | 51.4 | 41.2 | |
| Diabetes: | 0.205 | ||
| Insulin requiring (%) | 6.1 | 9.7 | |
| Non-Insulin requiring (%) | 24.8 | 22.6 | |
| Not diabetic (%) | 69.1 | 67.7 | |
| Hypertension (%) | 62.7 | 59.7 | 0.241 |
| Hypercholesterolaemia (%) | 46.0 | 51.3 | 0.001 |
| Previous myocardial infarction (%) | 30.7 | 34.9 | 0.29 |
| Previous PCI (%) | 14.1 | 25.5 | <0.001 |
| Previous CABG (%) | 11.5 | 11.2 | 0.994 |
| Peripheral vascular disease (%) | 1.5 | 6.0 | 0.003 |
| Previous stroke (%) | 6.7 | 8.1 | 0.58 |
CABG, coronary artery bypass graft; HAC-X, Heart Attack Centre-Extension.